Fred Alger Management’s MaxCyte MXCT Stock Holding History

Fred Alger Management’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272K	Sell	386,667 -3,256	-0.8%	-$3.04K	﹤0.01%	407
2025 Q4	$604K	Sell	389,923 -181	-0%	-$289	﹤0.01%	387
2025 Q3	$616K	Hold	390,104	–	–	﹤0.01%	386
2025 Q2	$850K	Buy	390,104 +669	+0.2%	+$1.62K	﹤0.01%	367
2025 Q1	$1.06M	Hold	389,435	–	–	0.01%	327
2024 Q4	$1.62M	Sell	389,435 -183	-0%	-$692	0.01%	344
2024 Q3	$1.52M	Sell	389,618 -4,154	-1%	-$17.5K	0.01%	340
2024 Q2	$1.54M	Sell	393,772 -5,390	-1%	-$23.2K	0.01%	339
2024 Q1	$1.67M	Sell	399,162 -7,934	-2%	-$37.2K	0.01%	355
2023 Q4	$1.91M	Buy	407,096 +46,222	+13%	+$180K	0.01%	337
2023 Q3	$1.13M	Sell	360,874 -94	-0%	-$378	0.01%	356
2023 Q2	$1.66M	Buy	360,968 +269,209	+293%	+$1.24M	0.01%	350
2023 Q1	$454K	Hold	91,759	–	–	﹤0.01%	406
2022 Q4	$501K	Hold	91,759	–	–	﹤0.01%	400
2022 Q3	$596K	Hold	91,759	–	–	﹤0.01%	390
2022 Q2	$434K	Sell	91,759 -1,835	-2%	-$9.04K	﹤0.01%	402
2022 Q1	$654K	Sell	93,594 -495	-0.5%	-$3.38K	﹤0.01%	415
2021 Q4	$959K	Sell	94,089 -3,364	-3%	-$36.1K	﹤0.01%	407
2021 Q3	$1.19M	Buy	+97,453	New	+$1.47M	﹤0.01%	375

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Fred Alger Management's MXCT Position: Q1 2026 in Review

Fred Alger Management reduced its MaxCyte (MXCT) stake by 0.84% in Q1 2026, selling an estimated $3.04K and leaving 386,667 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Fred Alger Management first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.91M in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Fred Alger Management held 386,667 shares of MaxCyte worth $272K as of Q1 2026.
Fred Alger Management sold 3,256 MaxCyte shares in Q1 2026, an estimated $3.04K.
MaxCyte made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #407 holding.
Fred Alger Management first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
Fred Alger Management's MaxCyte position peaked at $1.91M in Q4 2023.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.